Will Cannabis Genetics Be Restricted?<

Will Cannabis Seeds Be Restricted?

The redefinition of hemp under federal law, set to take effect Nov. 12, spells the end of Farm Bill safeguards for numerous hemp-derived THC items across the nation: low-dose beverages as well as THCA flower and delta-8 THC edibles, vapes and other products sold at gas stops and https://nativesusa.com/ – https://nativesusa.com/ – smoke shops.

But the hemp ban also generates a major complication for the legitimate cannabis sector. Seeds from cannabis varieties that generate flower with greater than 0.3% THC are no longer legal to ship out of state.

Although seed purchases will probably continue in authorized states, the modifications threaten to shutter some seed suppliers and genetics businesses, observers say, while creating supply-chain issues for cannabis growers and retailers.

“If this language goes through, we will require pop-up shops to sell seeds in each state where it’s legal,” Campanella said. “Which is why we’re also offering clones and tissue cultivation, because that’s not included in the bill.”

When are cannabis seeds and clones illegal to ship between state lines?

The new regulations classify seeds depending on the THC potential of the parent plant. Genetic substances such as seeds and clones are rendered illegal if the end product exceeds the threshold.

For now, seeds are still shipping under the 2018 Farm Bill’s current quo. But the time is ticking for businesses like Brothers Grimm and for cannabis growers who worry about supply chain interruptions if out-of-state availability to genetics is banned.

Most of the cannabis industry remains mostly unaware of the approaching shutdown of the interstate genetics marketplace, said Ryan Power, cofounder of Sebastopol, California-based company Atlas Seed.

Without government intervention in the way of an exception for seeds or an overall moratorium, numerous seed suppliers will just be shuttered come November, he added.

“We are operating legally currently, but if that shifts, it will upend the legitimate licensed industry in every state,” said Power, whose customers includes seed suppliers as well as licensed commercial cultivators.

“Customers are going to forfeit choice, and it will be a major shutdown for many people.”

What are cannabis seed suppliers doing to remain legal after the federal hemp ban?

Sagui Silber has previously recalibrated Silberhaze Genetics, his Ohio genetics business, because of state Senate Bill 56, which tightened cannabis oversight in that state while also restricting hemp-derived THC products to licensed cannabis retailers.

Previously a seed bank, Silberhaze is now focused on the marketing, preservation and IP safeguarding of premium plant genetics.

That’s because seed businesses hoping to stay compliant in this updated environment must have solid documentation, he said.

“You have to prove where this material comes from, so it’s very important to have records, even to the point where you have cultivator names,” Silber said.

“Small businesses will have to operate with better records and a stronger chain of custody,” he added. “We need that documentation too, because we don’t want to be dealing with questionable sources.”

To avoid seizures and other legal fallout, seed entrepreneurs must “get their ducks in a row” before the new regulations take place, Silber said.

“Audit all your stuff immediately, and classify what you can,” Silber said. “Take stock, document your heritage, preserve breeder records, and organize any cannabinoid or terpene data you currently have. If regulations change, you’ll be in a much better position to comprehend what may be impacted and make educated decisions.”

Does government marijuana rescheduling impact cannabis genetics?

Silber believes U.S. Drug Enforcement Administration licensing may be required for companies engaged in research.

But for now, seed houses can’t register with the DEA like state-licensed therapeutic cannabis businesses can. Such a pathway is unavailable to seed banks, nurseries or genetics companies, said Jim Ickes, a lawyer and partner with Frantz Ward’s cannabis practice group in Cleveland.

“Seed-related activity may be happening inside broader state-licensed medical marijuana operations, as some states allow dispensaries or registered medical operators to sell seeds, clones or personal growing materials,” he said.

“But that is distinct from the DEA establishing a freestanding seed supplier registration category.”

Some genetics operators are already changing operational practices to comply with the updated law. According to Ickes, they must answer questions including:

• Which of our varieties produce plants above 0.3% total THC?
• Which seeds remain as hemp after Nov. 12, 2026, and which don’t?
• What does our inventory look like once we sort it against the viable-seed exclusion?

Ickes also recognizes confusion from customers who believed federal rescheduling of therapeutic marijuana would clarify their situation with banking institutions. However, the latest regulatory language has shifted those conversations beyond the basics of classification, he said.

“Financial institutions ask whether this specific revenue stream is legal, whether it ties to state-licensed operations, or whether there’s interstate-commerce risk,” said Ickes.

“After November, a seed supplier selling high-THC genetics can’t address the initial question with the hemp classification. It has to point to a legal state cannabis pathway instead. Seed banks dealing in authentic industrial-hemp seed maintain the cleaner story.”

What’s the future of cannabis genetics?

Campanella is a member of a emerging coalition of other breeders, farmers and researchers that’s arguing seeds are better defined as agricultural inputs than controlled substances. To that effect, seeds should be managed by the U.S. Department of Agriculture, allowing the DEA to concentrate its enforcement work elsewhere.

“How do you regulate something based on what it could become one day?” said Campanella. “Our choice is to have that wording removed, or have seeds regulated by the USDA as a hemp product.”

But in the interim, Campanella is restructuring Brothers Grimm to operate outside the reach of shifting federal oversight. The business plans to maintain its Colorado seed operation while positioning its Oklahoma tissue cultivation facility as a safeguard against government prohibition of cannabis seeds.

As she noted: “If things evolve in a way where we can’t concentrate on interstate shipping, we’ll have other resources to meet people’s requirements without getting ourselves in trouble.”